Flora E. van Leeuwen
Researcher Next ID · RN-033812
Researcher · Biochemistry, Genetics and Molecular Biology
The Netherlands Cancer Institute
Amsterdam, Netherlands
- Works count
- 742
- Citation count
- 41,360
- H-index
- 97
- i10-index
- 359
Research interests
Publications
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
JAMA · 2017 · https://doi.org/10.1001/jama.2017.7112
European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk
Cancer Epidemiology · 2015 · https://doi.org/10.1016/j.canep.2015.05.009
Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
Journal of Clinical Oncology · 2015 · 10.1200/jco.2015.63.4444
Cardiovascular Disease After Hodgkin Lymphoma Treatment
JAMA Internal Medicine · 2015 · 10.1001/jamainternmed.2015.1180
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma
New England Journal of Medicine · 2015 · 10.1056/nejmoa1505949
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
PLoS Genetics · 2013 · https://doi.org/10.1371/journal.pgen.1003212
Health Council of the Netherlands: No need to change from SAR to time-temperature relation in electromagnetic fields exposure limits
International Journal of Hyperthermia · 2011 · https://doi.org/10.3109/02656736.2010.534528
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
PLoS Medicine · 2010 · https://doi.org/10.1371/journal.pmed.1000279
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
JNCI Journal of the National Cancer Institute · 2010 · https://doi.org/10.1093/jnci/djq526
Cardiometabolic Differences in Children Born After in Vitro Fertilization: Follow-Up Study
The Journal of Clinical Endocrinology & Metabolism · 2008 · 10.1210/jc.2007-2432
Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer
JNCI Journal of the National Cancer Institute · 2007 · https://doi.org/10.1093/jnci/djk064
Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer
Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.10.5296
Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer
JAMA · 2007 · https://doi.org/10.1001/jama.297.24.2705
Physical Activity and Breast Cancer
Epidemiology · 2006 · 10.1097/01.ede.0000251167.75581.98
Late cardiotoxicity after treatment for Hodgkin lymphoma
Blood · 2006 · https://doi.org/10.1182/blood-2006-07-034405
Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma
JNCI Journal of the National Cancer Institute · 2005 · 10.1093/jnci/dji290
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
Journal of Clinical Oncology · 2003 · 10.1200/jco.2003.07.131
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
JAMA · 2003 · 10.1001/jama.290.4.465
Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease
JNCI Journal of the National Cancer Institute · 2003 · 10.1093/jnci/95.13.971
Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years
Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.09.038
Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood
Journal of Clinical Oncology · 2000 · 10.1200/jco.2000.18.3.487
Risk and prognosis of endometrial cancer after tamoxifen for breast cancer
The Lancet · 2000 · 10.1016/s0140-6736(00)02677-5
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
JNCI Journal of the National Cancer Institute · 1997 · 10.1093/jnci/89.19.1429
Risk of endometrial cancer after tamoxifen treatment of breast cancer
The Lancet · 1994 · 10.1016/s0140-6736(94)92692-1
Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
Journal of Clinical Oncology · 1994 · 10.1200/jco.1994.12.2.312
Leukemia Following Hodgkin's Disease
New England Journal of Medicine · 1990 · https://doi.org/10.1056/nejm199001043220102
Current projects
No projects listed.